Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04026776 · ClinicalTrials.gov registry record · Early Phase 1
Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm
A Early Phase 1 study of Blood Pressure Disorders and Salt; Excess, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04026776: Recruiting Early Phase 1 study of Blood Pressure Disorders and Salt; Excess, sponsored by Wake Forest University Health Sciences.
NCT04026776 is a Early Phase 1 study of Blood Pressure Disorders and Salt; Excess that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 120 participants, below the 498-participant average among 7 other Blood Pressure Disorders trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04026776, a Early Phase 1 study of Blood Pressure Disorders and Salt; Excess, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to learn about how salt in the diet influences blood pressure in young adults who were born prematurely.
Primary Outcome
Defined as a ≥8 mmHg decrease in mean arterial blood pressure when moving from the high-Na+ to the low-Na+ phase, as measured on 24-hour ambulatory blood pressure monitoring (ABPM).
Conditions Studied
Interventions
- OTHER Dietary Intervention
- DRUG Allopurinol
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-09-02 |
| Est. Completion | 2026-06 |
| Phase | Early Phase 1 |
What NCT04026776 shows while recruiting
NCT04026776 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 498-participant average among 7 other Blood Pressure Disorders trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Blood Pressure Disorders appearing as the primary indexed condition, and to 2 interventions - of which Dietary Intervention is the first listed.
NCT04026776 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04026776 about?
NCT04026776 is a clinical study titled "Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm". The purpose of this research is to learn about how salt in the diet influences blood pressure in young adults who were born prematurely.
What is the current status of trial NCT04026776?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 120 participants. The study started on 2020-09-02. Estimated completion is 2026-06.
What conditions does trial NCT04026776 study?
This clinical trial studies the following conditions: Blood Pressure Disorders, Salt; Excess.
What interventions are being tested in trial NCT04026776?
The interventions under investigation include: Dietary Intervention (OTHER), Allopurinol (DRUG).
Who is sponsoring clinical trial NCT04026776?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04026776 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI
RECRUITING · NA
-
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
RECRUITING
-
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
RECRUITING
-
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
RECRUITING · NA
-
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
COMPLETED · NA
-
Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI